Biggest News Aggregation in the World
📰 Advance Development News

Page 3 - Advance Development News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Advance Development. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Theravance Biopharma, Inc.: Theravance Biopharma to Sell TRELEGY ELLIPTA Royalty Interests to Royalty Pharma for Approximately $1.1 Billion in Upfront Cash with Over $1.5 Billion in Potential Total Value

Over $1.5 Billion in Potential Total Value, Including Approximately $1.1 Billion in Upfront Cash, up to $250 Million in Sales-Based Milestone Payments and an Estimated NPV Approximately $200
Ricke Winningham Pablo Legorreta Theravance Biopharma Gail Cohen Exchange For Unsecured Low Single Theravance Biopharma Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science